Identification of the risk factors for development of CMV virema associated with low dose Valganciclovir prophylaxis in obese kidney transplant recipients
Latest Information Update: 07 Oct 2016
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 07 Oct 2016 New trial record